These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1578318)
41. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults. Ziemniak JA; Assael BM; Padoan R; Schentag JJ Eur J Clin Pharmacol; 1984; 26(2):183-9. PubMed ID: 6723756 [TBL] [Abstract][Full Text] [Related]
42. Removal of prednisone and prednisolone by plasma exchange. Stigelman WH; Henry DH; Talbert RL; Townsend RJ Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876 [TBL] [Abstract][Full Text] [Related]
49. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis. Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395 [TBL] [Abstract][Full Text] [Related]
50. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. Konstan MW; Hoppel CL; Chai BL; Davis PB J Pediatr; 1991 Jun; 118(6):956-64. PubMed ID: 2040934 [TBL] [Abstract][Full Text] [Related]
51. Renal handling of prednisolone/prednisone: effect of steroid dose and 11 beta-hydroxysteroid dehydrogenase. Conti M; Frey FJ; Escher G; Marone C; Frey BM Nephrol Dial Transplant; 1994; 9(11):1622-8. PubMed ID: 7870352 [TBL] [Abstract][Full Text] [Related]
52. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition. Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348 [TBL] [Abstract][Full Text] [Related]
53. Theophylline disposition in cystic fibrosis. Isles A; Spino M; Tabachnik E; Levison H; Thiessen J; MacLeod S Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study. de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222 [TBL] [Abstract][Full Text] [Related]
55. The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients. Gambertoglio JG; Holford HG; Lizak PS; Birnbaum JL; Salvatierra O; Amend WJ Am J Kidney Dis; 1984 May; 3(6):425-9. PubMed ID: 6372445 [TBL] [Abstract][Full Text] [Related]
56. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743 [TBL] [Abstract][Full Text] [Related]
57. Montelukast pharmacokinetics in cystic fibrosis. Graff GR; Weber A; Wessler-Starman D; Smith AL J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255 [TBL] [Abstract][Full Text] [Related]